drugset / Trial / NCT03692416

The Effect of Some Drugs Used in Treatment of Vasculitis on the Complement System in Children

NCT03692416

Phase 3 Unknown 70 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

Vasculitis denotes affection of small to medium sized vessels by polyangitis. Antineutrophil cytoplasmic antibodies (ANCA) are immunoglobulin G (IgG) autoantibodies directed against constituents of neutrophil granules leading to neutrophil degeneration which results in cell apoptosis known as "Natoptosis" (NaTosis) of the cells. These lead to vessel endothelial cell damage. So that, ANCA formation seems to be the basic reaction in vasculitis. Complement activation at C3 and C4 was thought to be involved in renal damage ANCA associated vasculitis (AAV).

Timeline

Start
2018-11-11
Primary completion
2021-11-11
Completion
2022-05-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 30 mg/kg Oral
Comparator Ibuprofen Small molecule 40 mg/kg Oral
Comparator Methotrexate Small molecule 0.35 mg/kg Oral
Comparator Methotrexate Small molecule 0.65 mg/kg Oral
Comparator Methotrexate Small molecule 10 mg/m2 Oral
Comparator Methotrexate Small molecule 20 mg/m2 Oral
Comparator Methylprednisolone Other / unclassified 10 mg/kg
Comparator Methylprednisolone Other / unclassified 30 mg/kg
Comparator Prednisone Other / unclassified 0.05 mg/kg Oral
Comparator Prednisone Other / unclassified 2 mg/kg Oral

Indications